Correlation Between Bristol-Myers Squibb and IPC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and IPC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and IPC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol-Myers Squibb and IPC, you can compare the effects of market volatilities on Bristol-Myers Squibb and IPC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of IPC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and IPC.

Diversification Opportunities for Bristol-Myers Squibb and IPC

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bristol-Myers and IPC is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Bristol-Myers Squibb and IPC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IPC and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol-Myers Squibb are associated (or correlated) with IPC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IPC has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and IPC go up and down completely randomly.
    Optimize

Pair Corralation between Bristol-Myers Squibb and IPC

Considering the 90-day investment horizon Bristol-Myers Squibb is expected to generate 1.21 times more return on investment than IPC. However, Bristol-Myers Squibb is 1.21 times more volatile than IPC. It trades about 0.03 of its potential returns per unit of risk. IPC is currently generating about -0.06 per unit of risk. If you would invest  5,921  in Bristol-Myers Squibb on June 30, 2022 and sell it today you would earn a total of  1,115  from holding Bristol-Myers Squibb or generate 18.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy43.86%
ValuesDaily Returns

Bristol-Myers Squibb  vs.  IPC

 Performance (%) 
       Timeline  

Bristol-Myers Squibb and IPC Volatility Contrast

   Predicted Return Density   
       Returns  

Bristol-Myers Squibb

Pair trading matchups for Bristol-Myers Squibb

IPC

Pair trading matchups for IPC

The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against IPC as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. IPC's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, IPC's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to IPC.

Pair Trading with Bristol-Myers Squibb and IPC

The main advantage of trading using opposite Bristol-Myers Squibb and IPC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, IPC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IPC will offset losses from the drop in IPC's long position.
Bristol-Myers Squibb vs. Kibush Capital Corp
The idea behind Bristol-Myers Squibb and IPC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against IPC as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. IPC's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, IPC's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to IPC.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go